Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
April 23, 2026BMC CancerOpen Access

Development of a multiplex assay for early detection of pancreatic cancer in high-risk groups

View Full Paper
Ask AI
Bookmark
Share

Authors

SPSheng PanRKRamesh KarkiLLLisa A. Lai

Discussion

Loading...

Member takes

Overview

A novel assay detects pancreatic cancer early in high-risk populations, suggesting significant clinical potential.

Key Points

  • This research aims to develop a blood-based assay for the early detection of pancreatic cancer in high-risk groups.
  • Created a multiplex assay using mass spectrometry to analyze protein biomarkers in plasma.
  • Applied machine learning to establish a composite biomarker readout for PDAC detection.
  • Evaluated assay efficacy in multiple cohorts with Receiver Operating Characteristic analysis.
  • Achieved an area under the curve of 0.87 and classification accuracy of 75% for early-stage PDAC.
  • Demonstrated a positive predictive value exceeding 18% and a diagnostic odds ratio above 67 across high-risk groups.
  • Outperformed the FDA-approved CA19-9 in distinguishing early-stage PDAC cases from controls.

Cite This Study

Pan et al. (2026) studied this question.

synapsesocial.com/papers/69e9baa885696592c86ecafahttps://doi.org/10.1186/s12885-026-16058-3
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Development of a multi-analyte blood test for the early detection of pancreatic ductal adenocarcinoma (PDAC) and performance compared to CA19-9.2024
  2. 2Multiplexed Quantitation of Plasma Proteins by Targeted Mass Spectrometry for Early Diagnosis of Pancreatic Ductal Adenocarcinoma2025
  3. 3Abstract B027: A blood-based, multiplex protein biomarker signature shows superior performance in detection of early-stage pancreatic ductal adenocarcinoma (PDAC)2024
  4. 4Early detection of pancreatic ductal adenocarcinoma (PDAC) with a multiomic liquid biopsy.2026
  5. 5Abstract 7616: Early detection of pancreatic cancer with a multi-omic liquid biopsy2026